4
Changes in Ownership
Denali Therapeutics Inc. Filed Acc 0001714899-23-000123
President and CEO sold 2,526 shares at $25.03 ($63,226)
- President and CEO acquired 2,526 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Watts Ryan J. President and CEO | 2023-08-10 | Option exercise | +2,526 | $0.68 | $1,718 | 2,242,439 | I: show line 1 in the form |
| Watts Ryan J. President and CEO | 2023-08-10 | Sale | −2,526 | $25.03 | $63,226 | 2,239,913 | I: show line 2 in the form |
| Open-market sales · 2,526 sh · avg $25.03 · $63,226 | |||||||
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Exercise | Expires | Underlying | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|
| Watts Ryan J. President and CEO | 2023-08-10 | Option exercise · Stock Option (right to buy) | −2,526 | 1,118,091 | D: show line 3 in the form |
Loading xslF345X05/wk-form4_1692047595.xml…